EMMI leverages “the largest global database of binding data” to generate small molecule drugs in new chemical space to tackle hard targets.

Europe’s public transport infrastructure has a fundamental security flaw: the Chinese company that built the bus can decide ...

Terray Therapeutics ( a chemistry-first, AI-native biotech company, today announced the achievement of a discovery milestone in the company's multi-target collaboration with Bristol Myers Squibb .

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Schneider Electric technology is making the NHS National Rehabilitation Centre (NRC) more sustainable and giving patients ...

While EVs are growing by leaps and bounds in India, there have been multiple instances of fire accidents and battery failures from time to time. Why is this happening?

A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...

Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025 ...

Ametek Programmable Power Inc., a leading manufacturer of battery test systems, recently showcased its Mi-BEAM and i-BEAM ...

A San Diego medical technology company received FDA approval this morning for a device that could transform how patients get ...

BMS's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory ...

Terray Therapeutics gains drug discovery milestone in partnership with Bristol Myers Squibb: Los Angeles Friday, December 5, 2025, 14:00 Hrs [IST] Terray Therapeutics, a chemistry ...